Partnerships are central to accelerating access to innovative therapies. Backed by strong asset identification and evaluation capabilities, a broad view of emerging technologies, and deep expertise, our internationally experienced business development team brings cross-disciplinary strengths across medicine, pharmacy, and biochemistry—making us a trusted partner in our core therapeutic areas.